Geode Capital Management
FTH

Geode Capital Management’s Faeth Therapeutics FTH Stock Holding History

Geode Capital Management’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$300K Buy
+9,501
New +$190K ﹤0.01% 3780
2025
Q2 		– Sell
-7,535
Closed -$59.4K – 4514
2025
Q1 		$59.4K Buy
7,535
+91
+1% +$865 ﹤0.01% 4162
2024
Q4 		$73K Sell
7,444
-713
-9% -$7.15K ﹤0.01% 4171
2024
Q3 		$97.6K Hold
8,157
– – ﹤0.01% 4109
2024
Q2 		$101K Buy
8,157
+1,341
+20% +$27.9K ﹤0.01% 4140
2024
Q1 		$143K Hold
6,816
– – ﹤0.01% 4040
2023
Q4 		$94.3K Hold
6,816
– – ﹤0.01% 4202
2023
Q3 		$102K Buy
6,816
+1,916
+39% +$41.2K ﹤0.01% 4242
2023
Q2 		$112K Hold
4,900
– – ﹤0.01% 4293
2023
Q1 		$147K Hold
4,900
– – ﹤0.01% 4179
2022
Q4 		$146K Buy
4,900
+305
+7% +$8.97K ﹤0.01% 4246
2022
Q3 		$142K Hold
4,595
– – ﹤0.01% 4387
2022
Q2 		$208K Sell
4,595
-8,196
-64% -$307K ﹤0.01% 4236
2022
Q1 		$590K Sell
12,791
-35
-0.3% -$2.79K ﹤0.01% 3860
2021
Q4 		$1.49M Sell
12,826
-873
-6% -$130K ﹤0.01% 3527
2021
Q3 		$2.88M Buy
13,699
+6,609
+93% +$1.2M ﹤0.01% 3201
2021
Q2 		$1.38M Buy
7,090
+1,220
+21% +$301K ﹤0.01% 3440
2021
Q1 		$1.71M Buy
+5,870
New +$1.96M ﹤0.01% 3334

Other funds holding FTH

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Geode Capital Management's FTH Position: Q1 2026 in Review

Geode Capital Management opened a new position in Faeth Therapeutics (FTH) in Q1 2026: 9,501 shares worth $300K. The stake represents ﹤0.01% of the portfolio and ranks #3780 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in FTH as recently as Q1 2025.

Geode Capital Management first reported a position in FTH in Q1 2021 and has held it in 18 quarters since. The position peaked at $2.88M in Q3 2021. 30 funds tracked by Wall St. Rank hold FTH as of Q1 2026.

  • Geode Capital Management held 9,501 shares of Faeth Therapeutics worth $300K as of Q1 2026.
  • Faeth Therapeutics was a new Geode Capital Management position in Q1 2026.
  • Faeth Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3780 holding.
  • Geode Capital Management first reported a position in Faeth Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • Geode Capital Management's Faeth Therapeutics position peaked at $2.88M in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.